Optical coherence tomography and visual field testing both essential

Article

Both structural and functional testing are important when diagnosing glaucoma and managing the condition in patients who have the disease.

"The question of imaging versus visual fields in glaucoma is a tongue-in-cheek discussion to some degree," Dr. Wooldridge said. "You really need both."

Visual field testing (VFT) using standard automated perimetry faces several "charges" in some quarters, in that VFT:

Advances in perimetry, such as short wavelength automated perimetry (SWAP) and frequency doubling technology, have increased sensitivity compared with standard automated perimetry. These newer technologies allow optometrists to detect VFL earlier in the disease process. They also utilize stimuli and patterns of presentation that target and allow the monitoring of select subpopulations of retinal ganglion cells.

In addition, improvements in software allow test times to be halved, reducing patient fatigue and increasing the reliability of the results, Dr. Wooldridge said. In addition, achromatic VFTs are the primary measure of progression in more advanced disease.

No single "best" perimeter or VFT for the early detection of glaucomatous damage exists, Dr. Wooldridge said. Some patients' damage will be detected first by SWAP, some by FDT, and some by standard automated perimetry.

The importance of using imaging along with visual fields can't be overestimated because structural damage precedes functional change; nerve fiber layer injury can be observed up to 6 years before visual field defects become evident, as noted by Sommer, Katz, Quigley, et al.

Imaging via the current state-of-the-art spectral domain optical coherence tomography (OCT) provides information about the optic nerve head, ganglion cell complex, retinal nerve fiber layer (RNFL), and other structures, and it enables glaucoma progression analyses that include thickness maps, changes in optic disc parameters, temporal superior nasal inferior temporal graph comparisons, RNFL trend analysis, and changes in RNFL parameters.

Recent Videos
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Although 2025 is predicted to remain stable, the forecast for the optical industry still remains uncertain.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Prominent legislation includes the Corporate Transparency Act and last year's spending bill provision that was struck down.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Steven T. Reed, OD, talks Optometry's Meeting and public-facing initiatives that optometrists can take advantage of.
For Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, last week's conference gives a unique opportunity for optometrists and ophthalmologists to collaborate.
Steven T. Reed, OD, American Optometric Association's president, overviews the 2024 highlights and how the organization plans to extend success into 2025.
Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.
© 2025 MJH Life Sciences

All rights reserved.